Elanco Animal Health Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NYSE, led by CEO Jeffrey N. Simmons, with a market cap of $10.9B.
Based on Q1 2026 filing
Common questions about Elanco Animal Health Inc.
Elanco Animal Health Inc. (ELAN) has a market capitalization of $10.9B and trades on NYSE.
Elanco Animal Health Inc. has approximately 9,800 employees.